Hello, and welcome to Virtual Investor Conferences . On behalf of the Life Sciences Investor Forum and our co-host Zacks Small Cap Research, we're very pleased you joined us for our quarterly ...

When struggling with understanding or dealing with emotions, there are differences between allowing, expressing, and ...

Luspatercept-aamt shows significant survival benefits and transfusion independence in lower-risk MDS, reshaping treatment ...

OPKO Health, Inc. (NASDAQ: OPK) (“OPKO”) and Entera Bio Ltd. (NASDAQ: ENTX) (“Entera”) today announced that their abstract “First-in-Class Oral GLP-2 Analog for Treatment of Short Bowel Syndrome” has ...

During a live event, Thomas LeBlanc, MD, MA, discussed dose escalation of luspatercept in myelodysplastic syndromes and ...

Many semaglutide users deviate from recommended dose‐escalation schedules and discontinue treatment, highlighting the need ...

Around a fifth of users report not losing the expected amounts of weight on Mounjaro, and doctors have some answers ...

In a lawsuit filed against Middlesex Health System, Inc., Middlesex Hospital, and Middlesex Health Services, Inc. at Superior ...

Rama Jamal Alhashemi has yet to catch an episode of Breaking Bad. She’d like to when time permits, but she has been far too busy.

OPKO Health, Inc. (NASDAQ: OPK) is one of the 10 best healthcare penny stocks to buy according to analysts. On June 25, the ...

The 85th American Diabetes Association Scientific Sessions have shown the depth of China’s play for the GLP-1 market, with Corxel Pharmaceuticals and Sciwind Biosciences among the companies to share ...

In an early look at SCOT-HEART 2, CCTA led more primary-prevention patients to make changes to reduce their risk of CVD.